Cite
HARVARD Citation
Gabriëls, R. et al. (n.d.). DOP15 Fluorescent labelled vedolizumab for real-time visualization and quantification of local drug distribution and pharmacodynamics in Inflammatory Bowel Diseases during endoscopy. Journal of Crohn's and colitis. pp. i064-i065. [Online].